The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just topped up....while panic underway....
Back to Feb's SP; I remember the despondency on this BB back then, then the excitement and bullishness after 3-4 good RNSs (Neuro-Bio, Unilever, top 15 Pharma etc); now back to pessimism again; the SP ebbs and flows, fundamentals are still the same (actually, better than in Feb).
Spoke too soon ..now 10% down
Just had some news....we are now 7% down on the day
Don't panic... no news is good news :)
Someone needed to sell a lot, quickly; good buying opportunity IMO, we're back at early Febr. SP.
Ouch
Excellent, well informed post, Thanks LTB
As per previous RNSs, APTA has had a relationship with this Top 5 Pharma since 2020, during which they delivered on +10 contracts; so, although an agreement could be reached in May (or June?), the important thing is that it's a matter of When, not If; remember that the Co referred to potential (long-term) licensing income of 6-8 mln, back in February, so we are looking at potentially 3-5 mln from this deal (not immediate, but enough to put APTA on the Market's radar).
GLA, DYOR
Certainly appears so and mindful that it's over 4 months since trials began...timing seems perfect for an imminent news update!
Well, something's brewing for sure as per Feb 5th Turner Pope Research Note (not independent, BTW);
https://www.turnerpope.com/wp-content/uploads/2024/03/Aptamer_Group_plc_5_2_2024_FINAL_BG.pdf
"Delivery of just one of the larger, big pharma contracts presently under negotiation could be transformative for Aptamer, both financially and in terms of industrywide reputation."
As forever the optimist with regards to well run companies I'm sticking my neck out and guessing 4 months ....news now due.... excellent news ...but DYOR..
As per Febr. 5th update, "Developed binders for IHC are now undergoing external validation by a top 5 pharma company, with initial results reported as promising and leading to a commercial request for more material.", thus we are already well into the 4th month of validation; anyone knows what's a reasonable period for such validations?
Fully agreed karl.. ...Despite these uncertainties, the current share price presents an opportunity that, in my view, justifies an investment of a significant sum!!!
Upon reviewing the Regulatory News Service announcement concerning the holdings, it appears that major shareholders maintain a strong sense of confidence.
Considering the ambitions surrounding Bio Markers and the burgeoning interest from prominent Bio Companies, it is prudent to deliberate whether it's too soon to deem the product a valuable asset or if the company is merely a minor player in an arena of giants.
Despite these uncertainties, the current share price presents an opportunity that, in my view, justifies an investment of a significant sum.
The Risk to me is a placing , anything can happen .....be prudent and sensible
You crafty tinker!
I sincerely hope not!
HELLO,
IS A PLACING COMING?
0.3-0.5p?
Last trade 0.7p....fingers crossed for a reversal
Personally, I'm happy to wait for value added news, as we are still up over the past week and sooner or later we will rise again...on sentiment or ideally ...news.
Ffs why can't this just hold on the there gains 😔 like watching paint dry need money 🤑 to start flowing via RNS soon or I fear another cash raise regardless what one of the BOD said this is the aim casino as we all know ...we need cash in the bank not promising cash in the bank
I agree ...They are buying trades 🤔
Looks like it's gone quiet until we hear more news again.
Very odd trades this morning.
Everything reported as a sell, but the bid changing up on the last few...
Wonder if they are filing another big order.
Good luck holders.
Eitherway, I don't begrudge anyone taking profits, but they may well find it expensive to buy back in. Time / news will tell.
Low volume day, MM’s dropping it on Zilch, don’t fall for it.